NovoCure Limited (NVCR) has a market capitalization of $1.29B and trades at $11.30. The 52-week range is 9.82-20.06.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -9.3, Earnings Per Share (EPS) of $-1.22, annual revenue of $655.35M.
The stock has a beta of 0.82, operates in the Healthcare sector.
